<DOC>
	<DOCNO>NCT01110616</DOCNO>
	<brief_summary>The objective study test experimental reproducibility within-subject variability qEEG ( quantitative electroencephalogram ) use two probe compound : MK3134 lorazepam . This study test hypothesis EEG ( Electroencephalogram ) theta power , average across topographical region interest decrease 6 hour administration MK3134 compare placebo . The objective study test experimental reproducibility within-subject variability qEEG use two probe compound : MK3134 lorazepam .</brief_summary>
	<brief_title>EEG ( Electroencephalogram ) Platform Standardization Healthy Male Subjects ( 3134-010 )</brief_title>
	<detailed_description />
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<criteria>Subject male 18 40 year age The subject Body Mass Index ( BMI ) great equal 31 kg/m^2 prestudy ( screen ) visit Subject normal correct normal visual auditory acuity Subject nonsmoker and/or use nicotine nicotinecontaining product least approximately 6 month Subject righthanded Subject permanent cosmetic metallic object body interfere measurement Subject history stroke , chronic seizure , major neurological disorder Subject history neoplastic disease Subject current diagnosis prior history sleep apnea Subject history fainting blood draw Subject history significant head injury/trauma Subject current diagnosis history Bipolar illness , Schizophrenia , Attention Deficit Hyperactivity Disorder ( ADHD ) , claustrophobia Subject work night shift able avoid night shift work within 3 day treatment visit Subject currently regular user illicit drug significant history drug ( include alcohol ) abuse</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>EEG Standardization</keyword>
</DOC>